Copenhagen, Denmark

Niels Dyhr Christensen

This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Niels Dyhr Christensen. Retrieved from https://idiyas.com/inventor/niels-dyhr-christensen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Niels Dyhr Christensen: Innovator in Aprotinin Variants

Introduction

Niels Dyhr Christensen is a notable inventor based in Kopenhagen, Denmark. He has made significant contributions to the field of biochemistry, particularly through his work on aprotinin variants. His innovative approach has led to advancements in enzyme-inhibitory, immunological, and pharmacokinetic properties.

Latest Patents

Niels holds a patent for "Aprotinin variants having improved properties." This invention relates to the development of aprotinin variants that exhibit enhanced enzyme-inhibitory, immunological, and pharmacokinetic properties. The patent highlights the preparation methods for these variants, showcasing Niels' expertise in the field.

Career Highlights

Niels Dyhr Christensen is associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His work at Bayer has allowed him to focus on innovative solutions that address critical health challenges.

Collaborations

Throughout his career, Niels has collaborated with esteemed colleagues such as Werner Schröder and Søren Bjørn. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Niels Dyhr Christensen's contributions to the field of biochemistry, particularly through his patent on aprotinin variants, demonstrate his commitment to innovation and improvement in healthcare solutions. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…